Chronic migraine with medication overuse: Association between disability and quality of life measures, and impact of disease on patients' lives

Alberto Raggi, Silvia Schiavolin, Matilde Leonardi, Ambra Mara Giovannetti, Gennaro Bussone, Marcella Curone, Paola Di Fiore, Licia Grazzi, Susanna Usai, Domenico D'Amico

Research output: Contribution to journalArticle

Abstract

Patients with chronic migraine with medication overuse (CM-MO) have decreased quality of life (QoL) and increased disability: the degree to which these outcomes are connected to disease severity and the pattern of MO towards disease severity are unclear. Patients under withdrawal were administered the Migraine Disability Assessment (MIDAS), the WHO Disability Assessment Schedule (WHODAS), and the Migraine-Specific Quality of Life Questionnaire (MSQ). They overused NSAIDs, triptans, NSAIDs and triptans, and other drugs (ergotamine, caffeine, opioids/barbiturates). We calculated the correlations between MIDAS, WHODAS, and MSQ; compared WHODAS to normative scores; compared MIDAS, WHODAS, and MSQ in patients with different CM-MO severity; and run a logistic regression to predict CM-MO severity based on overused drugs. One hundred ninety-four patients were enrolled: correlations between WHODAS, MSQ, and MIDAS were moderate; wide differences on WHODAS against normative were found; and no trend was found across severity groups. Compared to triptans overusers, patients overusing NSAID and other drugs had higher odds of severe CM-MO. Coupling different disability measures with QoL assessment offered different insights on the lived experience of CM-MO. Future studies are needed to clarify the relationship between overused drugs and CM-MO severity: we added evidence that NSAIDs do not have protective effect in high-frequency CM-MO.

Original languageEnglish
Pages (from-to)60-66
Number of pages7
JournalJournal of the Neurological Sciences
Volume348
Issue number1-2
DOIs
Publication statusPublished - Jan 15 2015

Fingerprint

Migraine Disorders
Quality of Life
Appointments and Schedules
Non-Steroidal Anti-Inflammatory Agents
Tryptamines
Pharmaceutical Preparations
Prescription Drug Overuse
Barbiturates
Opioid Analgesics
Logistic Models

Keywords

  • Chronic migraine
  • Detoxification
  • Disability
  • Health-related quality of life
  • Medication overuse
  • Withdrawal

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Chronic migraine with medication overuse : Association between disability and quality of life measures, and impact of disease on patients' lives. / Raggi, Alberto; Schiavolin, Silvia; Leonardi, Matilde; Giovannetti, Ambra Mara; Bussone, Gennaro; Curone, Marcella; Di Fiore, Paola; Grazzi, Licia; Usai, Susanna; D'Amico, Domenico.

In: Journal of the Neurological Sciences, Vol. 348, No. 1-2, 15.01.2015, p. 60-66.

Research output: Contribution to journalArticle

@article{914d58e15e294d82b7284468b87d673f,
title = "Chronic migraine with medication overuse: Association between disability and quality of life measures, and impact of disease on patients' lives",
abstract = "Patients with chronic migraine with medication overuse (CM-MO) have decreased quality of life (QoL) and increased disability: the degree to which these outcomes are connected to disease severity and the pattern of MO towards disease severity are unclear. Patients under withdrawal were administered the Migraine Disability Assessment (MIDAS), the WHO Disability Assessment Schedule (WHODAS), and the Migraine-Specific Quality of Life Questionnaire (MSQ). They overused NSAIDs, triptans, NSAIDs and triptans, and other drugs (ergotamine, caffeine, opioids/barbiturates). We calculated the correlations between MIDAS, WHODAS, and MSQ; compared WHODAS to normative scores; compared MIDAS, WHODAS, and MSQ in patients with different CM-MO severity; and run a logistic regression to predict CM-MO severity based on overused drugs. One hundred ninety-four patients were enrolled: correlations between WHODAS, MSQ, and MIDAS were moderate; wide differences on WHODAS against normative were found; and no trend was found across severity groups. Compared to triptans overusers, patients overusing NSAID and other drugs had higher odds of severe CM-MO. Coupling different disability measures with QoL assessment offered different insights on the lived experience of CM-MO. Future studies are needed to clarify the relationship between overused drugs and CM-MO severity: we added evidence that NSAIDs do not have protective effect in high-frequency CM-MO.",
keywords = "Chronic migraine, Detoxification, Disability, Health-related quality of life, Medication overuse, Withdrawal",
author = "Alberto Raggi and Silvia Schiavolin and Matilde Leonardi and Giovannetti, {Ambra Mara} and Gennaro Bussone and Marcella Curone and {Di Fiore}, Paola and Licia Grazzi and Susanna Usai and Domenico D'Amico",
year = "2015",
month = "1",
day = "15",
doi = "10.1016/j.jns.2014.11.004",
language = "English",
volume = "348",
pages = "60--66",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Chronic migraine with medication overuse

T2 - Association between disability and quality of life measures, and impact of disease on patients' lives

AU - Raggi, Alberto

AU - Schiavolin, Silvia

AU - Leonardi, Matilde

AU - Giovannetti, Ambra Mara

AU - Bussone, Gennaro

AU - Curone, Marcella

AU - Di Fiore, Paola

AU - Grazzi, Licia

AU - Usai, Susanna

AU - D'Amico, Domenico

PY - 2015/1/15

Y1 - 2015/1/15

N2 - Patients with chronic migraine with medication overuse (CM-MO) have decreased quality of life (QoL) and increased disability: the degree to which these outcomes are connected to disease severity and the pattern of MO towards disease severity are unclear. Patients under withdrawal were administered the Migraine Disability Assessment (MIDAS), the WHO Disability Assessment Schedule (WHODAS), and the Migraine-Specific Quality of Life Questionnaire (MSQ). They overused NSAIDs, triptans, NSAIDs and triptans, and other drugs (ergotamine, caffeine, opioids/barbiturates). We calculated the correlations between MIDAS, WHODAS, and MSQ; compared WHODAS to normative scores; compared MIDAS, WHODAS, and MSQ in patients with different CM-MO severity; and run a logistic regression to predict CM-MO severity based on overused drugs. One hundred ninety-four patients were enrolled: correlations between WHODAS, MSQ, and MIDAS were moderate; wide differences on WHODAS against normative were found; and no trend was found across severity groups. Compared to triptans overusers, patients overusing NSAID and other drugs had higher odds of severe CM-MO. Coupling different disability measures with QoL assessment offered different insights on the lived experience of CM-MO. Future studies are needed to clarify the relationship between overused drugs and CM-MO severity: we added evidence that NSAIDs do not have protective effect in high-frequency CM-MO.

AB - Patients with chronic migraine with medication overuse (CM-MO) have decreased quality of life (QoL) and increased disability: the degree to which these outcomes are connected to disease severity and the pattern of MO towards disease severity are unclear. Patients under withdrawal were administered the Migraine Disability Assessment (MIDAS), the WHO Disability Assessment Schedule (WHODAS), and the Migraine-Specific Quality of Life Questionnaire (MSQ). They overused NSAIDs, triptans, NSAIDs and triptans, and other drugs (ergotamine, caffeine, opioids/barbiturates). We calculated the correlations between MIDAS, WHODAS, and MSQ; compared WHODAS to normative scores; compared MIDAS, WHODAS, and MSQ in patients with different CM-MO severity; and run a logistic regression to predict CM-MO severity based on overused drugs. One hundred ninety-four patients were enrolled: correlations between WHODAS, MSQ, and MIDAS were moderate; wide differences on WHODAS against normative were found; and no trend was found across severity groups. Compared to triptans overusers, patients overusing NSAID and other drugs had higher odds of severe CM-MO. Coupling different disability measures with QoL assessment offered different insights on the lived experience of CM-MO. Future studies are needed to clarify the relationship between overused drugs and CM-MO severity: we added evidence that NSAIDs do not have protective effect in high-frequency CM-MO.

KW - Chronic migraine

KW - Detoxification

KW - Disability

KW - Health-related quality of life

KW - Medication overuse

KW - Withdrawal

UR - http://www.scopus.com/inward/record.url?scp=84920996909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920996909&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2014.11.004

DO - 10.1016/j.jns.2014.11.004

M3 - Article

C2 - 25434715

AN - SCOPUS:84920996909

VL - 348

SP - 60

EP - 66

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -